PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12.95%
Both yoy net incomes decline, with MRVL at -2786.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
6.84%
Some D&A expansion while MRVL is negative at -6.16%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
95.38%
Lower deferred tax growth vs. MRVL's 726.80%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
67.74%
SBC growth while MRVL is negative at -2.71%. John Neff would see competitor possibly controlling share issuance more tightly.
-9488.89%
Both reduce yoy usage, with MRVL at -93.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-87.59%
Both yoy AR lines negative, with MRVL at -106.25%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-50.42%
Both reduce yoy inventory, with MRVL at -37.92%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-464.71%
Negative yoy AP while MRVL is 9830.59%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-236.97%
Both reduce yoy usage, with MRVL at -2338.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1.59%
Well above MRVL's 0.79%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-43.19%
Both yoy CFO lines are negative, with MRVL at -43.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-1.55%
Negative yoy CapEx while MRVL is 18.55%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
18.30%
Purchases growth of 18.30% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
10.30%
Liquidation growth of 10.30% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
81.82%
Growth well above MRVL's 116.23%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
102.73%
We have mild expansions while MRVL is negative at -30.61%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-274.84%
We cut debt repayment yoy while MRVL is 89.20%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
70.00%
We slightly raise equity while MRVL is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
87.85%
Similar buyback growth to MRVL's 89.03%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.